Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Incyte Corporation is a biopharmaceutical company engaged in the discovery, development, and commercialization of therapeutics. It operates in three therapeutic areas: Hematology, Oncology, and Inflammation and Autoimmunity. Its hematology franchise includes four approved products, JAKAFI (ruxolitinib), ICLUSIG (ponatinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) and NIKTIMVO (axatilimab-csfr), as well as multiple clinical development programs. Its oncology franchise includes two approved products, PEMAZYRE (pemigatinib) and ZYNYZ (retifanlimab-dlwr), as well as several clinical development programs. Its Inflammation and Autoimmunity franchise consists of one approved product, OPZELURA (ruxolitinib) cream, with several clinical programs in development. It also includes VGA039, a novel monoclonal antibody in Phase III development for von Willebrand disease (VWD). It manages business activities through the development and commercialization of oncology and dermatology products.
Find out what a historical investment in Incyte Corporation would be worth today using our INCY stock calculator.
Buying INCY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Incyte Corporation in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in INCY
What is the ticker symbol of Incyte Corporation?
The ticker symbol for Incyte Corporation is INCY.
How much is one share of INCY?
One share of INCY is valued at $114.63 as of 22 November 2026.
What is the market capitalisation of Incyte Corporation INCY?
As of 22 November 2026 Incyte Corporation has a market cap of $23.36B.
What is the P/E ratio of INCY?
The Price to Earnings ratio of INCY is 61.61.
What is the Earnings Per Share of INCY?
The Earnings Per Share of INCY is $1.88.
What is the 52-week high for Incyte Corporation stock?
The Incyte Corporation 52-week high stock price is $132.60.
What is the 52-week low for Incyte Corporation stock?
The Incyte Corporation 52-week low stock price is $89.25.
Can I buy INCY shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy INCY shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in INCY on Stake
Buy INCY from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of INCY from only US$10 with fractional shares